Standard Biotools reported $9.84M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Agilent USD 845M 7M Mar/2026
Becton, Dickinson and Co. USD 2.67B 108M Jun/2026
Bio-Rad Laboratories USD 305.2M 22.5M Jun/2026
Bruker USD 422.5M 21.1M Jun/2026
Danaher USD 2.65B 294M Jun/2026
Illumina USD 389M 19M Jun/2026
Myriad Genetics USD 63M 1.1M Dec/2025
Nikon Corporation JPY 99.62B 15.43B Jun/2026
Pacific Biosciences Of California USD 28.9M 10M Dec/2025
Revvity USD 312.82M 10.64M Jun/2026
Roche Holding CHF 7.85B 630M Jun/2026
Sony JPY 1.8T 305.86B Jun/2026
Standard Biotools USD 9.84M 2.58M Mar/2026
Thermo Fisher Scientific USD 7.54B 577M Jun/2026
Waters USD 1.16B 430M Jun/2026